Filing metadata

Accession number
0001209191-22-013316
Form type
Form 4
Filer
Checkmate Pharmaceuticals, Inc.
CIK
CIK 1651431
Filed
Feb 25, 2022
Reporting period
Feb 23, 2022
Description
Insider transaction

Explore SEC Filings Hub